Feature Channels: Cell Biology

Filters close
Newswise: Stem Cell-Derived Therapy Shows Promise Against Treatment-Resistant Liver Cancer
Released: 9-Jul-2024 11:05 AM EDT
Stem Cell-Derived Therapy Shows Promise Against Treatment-Resistant Liver Cancer
University of California San Diego

Discover research from UC San Diego showing how stem cell-derived therapy, targeting treatment-resistant liver cancer through genetically modified NK cells, offers promising new avenues for immunotherapy.

Released: 2-Jul-2024 2:05 PM EDT
NanoCellect Launches VERLO: First Demonstration of Image-Based Sorting of Interacting Immune Synapsed Cells Followed by Confirmation of Immune Functionality
NanoCellect

NanoCellect Biomedical, a leader in microfluidic cell sorting technology, proudly announces the launch of VERLO™ Image-Guided Cell Sorter, a groundbreaking cell sorter poised to redefine the landscape of single-cell visualization and gentle flow cytometry analysis and cell sorting.

Newswise: UV Radiation Damage Leads to Ribosome Roadblocks, Causing Early Skin Cell Death
Released: 2-Jul-2024 1:30 PM EDT
UV Radiation Damage Leads to Ribosome Roadblocks, Causing Early Skin Cell Death
Johns Hopkins Medicine

In a recent study, researchers at Johns Hopkins Medicine suggest the cell’s messenger RNA (mRNA) — the major translator and regulator of genetic material — along with a critical protein called ZAK, spur the cell’s initial response to UV radiation damage and play a critical role in whether the cell lives or dies.

Released: 2-Jul-2024 11:05 AM EDT
Serendipity reveals new method to fight cancer with T cells
University of Wisconsin–Madison

A promising therapy that treats blood cancers by harnessing the power of the immune system to target and destroy cancer cells could now treat solid tumors more efficiently.

Newswise: New mRNA technology turns cells into long-lasting drug factories
Released: 2-Jul-2024 10:05 AM EDT
New mRNA technology turns cells into long-lasting drug factories
National Institute of Biomedical Imaging and Bioengineering

A team of researchers has established a ribonucleic acid (RNA)-based method that drives cells in the body to produce therapeutic proteins and secrete them into the bloodstream. The approach could potentially extend the lifespan of drugs in the body, reducing the burden on patients who require frequent drug administrations.

Newswise: Drugs that kill
28-Jun-2024 11:05 AM EDT
Drugs that kill "zombie" cells may benefit some older women, but not all, Mayo Clinic study finds
Mayo Clinic

Drugs that selectively kill senescent cells may benefit otherwise healthy older women but are not a "one-size-fits-all" remedy, Mayo Clinic researchers have found. Specifically, these drugs may only benefit people with a high number of senescent cells, according to findings publishing July 2 in Nature Medicine.

Newswise: Opportunistic Colonizers: Selectively Targeting Tumor Cells with Bacteria
Released: 1-Jul-2024 8:05 AM EDT
Opportunistic Colonizers: Selectively Targeting Tumor Cells with Bacteria
Chinese Academy of Sciences

Live bacteria can be applied in cancer therapy given their ability to deplete nutrients and induce cell death in tumors. However, the interaction between bacteria and tumor cells is risky and can exacerbate the inflammatory response and the expression of anti-apoptotic genes.

   
Released: 26-Jun-2024 12:00 PM EDT
Priming mesenchymal stem cells to develop “super stem cells”
World Journal of Stem Cells

The stem cell pre-treatment approaches at cellular and sub-cellular levels encompass physical manipulation of stem cells to growth factor treatment, genetic manipulation, and chemical and pharmacological treatment, each strategy having adva

Released: 26-Jun-2024 12:00 PM EDT
Priming mesenchymal stem cells to develop “super stem cells”
World Journal of Stem Cells

The stem cell pre-treatment approaches at cellular and sub-cellular levels encompass physical manipulation of stem cells to growth factor treatment, genetic manipulation, and chemical and pharmacological treatment, each strategy having adva

Released: 25-Jun-2024 7:05 AM EDT
CellFE Announces Addition of Life Science Tools Veteran Mike Rice to Board of Directors
CellFE

CellFE Inc., a cell engineering platform company with a novel microfluidic technology for non-viral cell therapy manufacturing, announced today that life science tools executive Mike Rice has been appointed to its Board of Directors.

Released: 24-Jun-2024 5:05 PM EDT
Heart disease model puts cells to work
Washington University in St. Louis

Researchers at Washington University in St. Louis can more effectively study mutations that cause heart disease by putting cells through their paces.

Newswise: Kevin Clark Named a Beckman Young Investigator
Released: 24-Jun-2024 2:05 PM EDT
Kevin Clark Named a Beckman Young Investigator
Tufts University

Kevin Clark, an assistant professor of chemistry at Tufts University, has been named a 2024 Beckman Young Investigator. The award, presented by the Arnold and Mabel Beckman Foundation, offers $600,000 in funding over four years to promising early career faculty members conducting “high-risk, high-reward work” that will address a broad range of problems.

Newswise: hemn-mohammadpour_landscape.jpg?itok=Bie8_nPl
Released: 20-Jun-2024 7:05 PM EDT
Roswell Park Insights on Role of Exportin 1 Protein Suggest Strategy for Improving Cancer Immunotherapy
Roswell Park Comprehensive Cancer Center

Research by Hemn Mohammadpour, DVM, PhD, and colleagues at Roswell Park Comprehensive Cancer Center offers new insights into tumor biology and may lay the groundwork for more effective cancer immunotherapy. Their preclinical findings were published today in the journal Cellular & Molecular Immunology.

Newswise: St. Jude scientists solve decades long mystery of NLRC5 sensor function in cell death
Released: 14-Jun-2024 3:40 PM EDT
St. Jude scientists solve decades long mystery of NLRC5 sensor function in cell death
St. Jude Children's Research Hospital

Learn about immunology research from the St. Jude laboratory of Thirumala-Devi Kanneganti, PhD, that revealed the function of the NLRC5 innate immune sensor. 

   
Released: 14-Jun-2024 3:05 PM EDT
Novel Gene-Editing Therapy Continues to Show Positive Results in Sickle Cell Patients
Cleveland Clinic

Researchers have presented the latest findings from a clinical trial aimed at discovering a cure for sickle cell disease, a painful genetic blood disorder with limited treatment options.

Released: 13-Jun-2024 5:05 PM EDT
High Prevalence of Errors Found in Lab-Made Plasmids Globally: Study Reveals Critical Quality Control Issues
VectorBuilder Inc

A new study conducted by VectorBuilder, a global leader in plasmid design and gene delivery solutions, has unveiled alarming rates of errors in lab-made plasmids worldwide.

   
Newswise: ‘Synthetic’ Cell Shown to Follow Chemical Directions and Change Shape, A Vital Biological Function
10-Jun-2024 10:00 AM EDT
‘Synthetic’ Cell Shown to Follow Chemical Directions and Change Shape, A Vital Biological Function
Johns Hopkins Medicine

In a feat aimed at understanding how cells move and creating new ways to shuttle drugs through the body, scientists at Johns Hopkins Medicine say they have built a minimal synthetic cell that follows an external chemical cue and demonstrates a governing principle of biology called “symmetry breaking.”

Newswise: Age is just a number: Immune cell ‘epigenetic clock’ ticks independently of organism lifespan 
Released: 12-Jun-2024 10:50 AM EDT
Age is just a number: Immune cell ‘epigenetic clock’ ticks independently of organism lifespan 
St. Jude Children's Research Hospital

See how St. Jude researchers use epigenetic clock, DNA methylation and mouse model to demonstrate that T cell proliferation can stretch past organism lifespan and acuta lymphoblastic leukemia T cells appear hundreds of years old.

Newswise: Discovery in hibernating animals could extend the shelf life of cells and tissues for transplantation  
Released: 11-Jun-2024 12:05 PM EDT
Discovery in hibernating animals could extend the shelf life of cells and tissues for transplantation  
NIH, National Eye Institute (NEI)

Research led by scientists at the National Eye Institute and Sun Yat-sen University, Guangzhou, China points to a potential strategy for extending the cold storage shelf life of donor cells and tissues, such as those of the pancreas, an organ crucial for making insulin.

Released: 11-Jun-2024 12:05 PM EDT
A novel spray device helps researchers capture fast-moving cell processes
SLAC National Accelerator Laboratory

Researchers figured out how to spray and freeze a cell sample in its natural state in milliseconds, helping them capture basic biological processes in unprecedented detail.



close
3.52747